Financial

Teva Pharmaceutical Industries reported stronger-than-expected results for the third quarter, supported by continued momentum in its portfolio of innovative medicines. The company also raised its full-year revenue forecast for its leading drug Austedo, which treats movement disorders linked to neurological conditions

Armis, the Israeli cybersecurity firm specializing in asset security and threat detection, has raised $435 million in a new funding round that values the company at $6.1 billion — an increase of more than 45% in just over a year. The round was led by Goldman Sachs Asset Management’s alternative investments division, with participation from CapitalG, Google’s investment arm and a long-time backer